Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03033953
Other study ID # Tine 12wk
Secondary ID
Status Completed
Phase N/A
First received January 19, 2017
Last updated January 24, 2017
Start date August 2014
Est. completion date November 2016

Study information

Verified date January 2017
Source Norwegian School of Sport Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the long term adaptations to 11 (elderly) or 12 (young) weeks of strength training when supplemented with native whey or milk. The investigators hypothesize that native whey will give greater increases in muscle hypertrophy and strength than milk.


Description:

Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than milk. Of special interest is the higher amounts of the highly anabolic amino acid leucine in native whey.

The higher levels of leucine can be of great interest for elderly individuals as some studies in elderly has shown an anabolic resistance to the effects of protein feeding and strength training. By increasing levels of leucine one might overcome this anabolic resistance in the elderly.

The aim of this double-blinded, randomized, partial cross-over study is to compare the changes in muscle hypertrophy and strength after a 11 (elderly) or 12 (young) week training intervention with daily supplementation of either 2x20g of native whey or milk proteins in young and elderly individuals. In order to explain potential differences between supplements an acute study investigating acute responses in blood amino acid concentrations and intracellular signalling is planned, in a subgroup of participants, before and after the training intervention.

The investigators hypothesize that native whey will induce greater muscle hypertrophy and strength gains than milk.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date November 2016
Est. primary completion date June 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Healthy in the sense that they can conduct training and testing

- Able to understand Norwegian language written and oral

- Between 20 and 45, or above 70 years of age

Exclusion Criteria:

- Diseases or injuries contraindicating participation

- Use of dietary supplements (e.g. proteins, vitamins and creatine)

- Lactose intolerance

- Allergy to milk

- Allergy towards local anesthetics (xylocain)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Native whey

Milk

Other:
Strength training


Locations

Country Name City State
Norway Norwegian School of Sport Sciences Oslo

Sponsors (3)

Lead Sponsor Collaborator
Norwegian School of Sport Sciences The Research Council of Norway, Tine

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lean mass Measured by whole body dual x-ray absorptiometry (DXA) Before the training intervention
Primary Lean mass Measured by whole body dual x-ray absorptiometry (DXA) After 11-12 weeks of strength training
Secondary Thigh muscle cross sectional area Measured by magnetic resonance imaging (MRI) Before the training intervention
Secondary Thigh muscle cross sectional area Measured by magnetic resonance imaging (MRI) After 11-12 weeks of strength training
Secondary Pectoralis muscle cross sectional area Measured by magnetic resonance imaging (MRI) Before the training intervention
Secondary Pectoralis muscle cross sectional area Measured by magnetic resonance imaging (MRI) After 11-12 weeks of strength training
Secondary Arm cross sectional area Measured by magnetic resonance imaging (MRI) Before the training intervention
Secondary Arm cross sectional area Measured by magnetic resonance imaging (MRI) After 11-12 weeks of strength training
Secondary Thickness of the lateral vasti Measured by ultrasound Before the training intervention
Secondary Thickness of the lateral vasti Measured by ultrasound After 11-12 weeks of strength training
Secondary 1 repetition maximum in leg press Before the training intervention
Secondary 1 repetition maximum in leg press After 11-12 weeks of strength training
Secondary 1 repetition maximum in bench press Before the training intervention
Secondary 1 repetition maximum in bench press After 11-12 weeks of strength training
Secondary Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline Biopsies from m. Vastus Lateralis was analyzed by western blot 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
Secondary Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline Biopsies from m. Vastus Lateralis was analyzed by western blot 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline Biopsies from m. Vastus Lateralis was analyzed by western blot 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
Secondary Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline Biopsies from m. Vastus Lateralis was analyzed by western blot 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline Biopsies from m. Vastus Lateralis was analyzed by western blot 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
Secondary Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline Biopsies from m. Vastus Lateralis was analyzed by western blot 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Plasma amino acid concentration 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
Secondary Plasma amino acid concentration 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Muscle force generating capacity change from baseline Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints. 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
Secondary Muscle force generating capacity change from baseline Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints. 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Serum glucose 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
Secondary Serum glucose 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Serum insulin 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
Secondary Serum insulin 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Serum urea 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
Secondary Serum urea 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Serum creatine kinase 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
Secondary Serum creatine kinase 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
Secondary Tumor necrosis factor alfa messenger ribonucleic acid (mRNA) 30 min before exercise and protein intake, before training intervention
Secondary Tumor necrosis factor alfa mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Tumor necrosis factor alfa mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Tumor necrosis factor alfa mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 6 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 6 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 6 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 6 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 8 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 8 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 8 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 8 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Nuclear Receptor Subfamily 4 Group A Member 2 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Nuclear Receptor Subfamily 4 Group A Member 2 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Nuclear Receptor Subfamily 4 Group A Member 2 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Nuclear Receptor Subfamily 4 Group A Member 2 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 1b mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 1b mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 1b mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 1b mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 1 Receptor Antagonist mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 1 Receptor Antagonist mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 1 Receptor Antagonist mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 1 Receptor Antagonist mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 2 mRNA 30 min before exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 2 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 2 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 2 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 4 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 4 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 4 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 4 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 10 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 10 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 10 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 10 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary C-X-C Motif Chemokine Ligand mRNA 30 min before exercise and protein intake, before training intervention
Secondary C-X-C Motif Chemokine Ligand mRNA 2 hours after exercise and protein intake, before training intervention
Secondary C-X-C Motif Chemokine Ligand mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary C-X-C Motif Chemokine Ligand mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Cholesterol 25-Hydroxylase mRNA 30 min before exercise and protein intake, before training intervention
Secondary Cholesterol 25-Hydroxylase mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Cholesterol 25-Hydroxylase mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Cholesterol 25-Hydroxylase mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 8 mRNA 30 min before exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 8 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 8 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 8 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 17D mRNA 30 min before exercise and protein intake, before training intervention
Secondary Interleukin 17D mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Interleukin 17D mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Interleukin 17D mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 3 mRNA 30 min before exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 3 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 3 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 3 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA 30 min before exercise and protein intake, before training intervention
Secondary Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary C-X-C Motif Chemokine Ligand 16 mRNA 30 min before exercise and protein intake, before training intervention
Secondary C-X-C Motif Chemokine Ligand 16 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary C-X-C Motif Chemokine Ligand 16 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary C-X-C Motif Chemokine Ligand 16 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 5 mRNA 30 min before exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 5 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary C-C Motif Chemokine Ligand 5 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary C-C Motif Chemokine Ligand 5 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Nuclear Receptor Subfamily 4 Group A Member 3 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Nuclear Receptor Subfamily 4 Group A Member 3 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Nuclear Receptor Subfamily 4 Group A Member 3 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Nuclear Receptor Subfamily 4 Group A Member 3 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Uncoupling Protein 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Uncoupling Protein 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Uncoupling Protein 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Uncoupling Protein 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Matrix Metallopeptidase 9 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Matrix Metallopeptidase 9 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Matrix Metallopeptidase 9 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Matrix Metallopeptidase 9 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary ATP Binding Cassette Subfamily A Member 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary ATP Binding Cassette Subfamily A Member 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary ATP Binding Cassette Subfamily A Member 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary ATP Binding Cassette Subfamily A Member 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Leukocyte Differentiation Antigen CD36 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Leukocyte Differentiation Antigen CD36 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Leukocyte Differentiation Antigen CD36 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Leukocyte Differentiation Antigen CD36 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Toll Like Receptor 2 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Toll Like Receptor 2 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Toll Like Receptor 2 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Toll Like Receptor 2 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Nuclear Receptor Subfamily 1 Group H Member 3 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Nuclear Receptor Subfamily 1 Group H Member 3 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Nuclear Receptor Subfamily 1 Group H Member 3 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Nuclear Receptor Subfamily 1 Group H Member 3 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 3 Member 2 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Solute Carrier Family 3 Member 2 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Solute Carrier Family 3 Member 2 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 3 Member 2 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 7 Member 5 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Solute Carrier Family 7 Member 5 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Solute Carrier Family 7 Member 5 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 7 Member 5 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 36 Member 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Solute Carrier Family 36 Member 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Solute Carrier Family 36 Member 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 36 Member 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 38 Member 2 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Solute Carrier Family 38 Member 2 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Solute Carrier Family 38 Member 2 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Solute Carrier Family 38 Member 2 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Muscle-Specific RING Finger Protein 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Muscle-Specific RING Finger Protein 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Muscle-Specific RING Finger Protein 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Muscle-Specific RING Finger Protein 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Atrogin-1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Atrogin-1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Atrogin-1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Atrogin-1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Forkhead Box Protein O1A mRNA 30 min before exercise and protein intake, before training intervention
Secondary Forkhead Box Protein O1A mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Forkhead Box Protein O1A mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Forkhead Box Protein O1A mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Forkhead Box O3 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Forkhead Box O3 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Forkhead Box O3 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Forkhead Box O3 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Myosin Heavy Chain 7 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Myosin Heavy Chain 7 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Myosin Heavy Chain 7 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Myosin Heavy Chain 7 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Myosin Heavy Chain 2 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Myosin Heavy Chain 2 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Myosin Heavy Chain 2 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Myosin Heavy Chain 2 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Myosin Heavy Chain 1mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Myostatin mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Myostatin mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Myostatin mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Myostatin mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Filamin B mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Filamin B mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Filamin B mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Filamin B mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, after 11-12 weeks of strength training
Secondary Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, before training intervention
Secondary Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA 2 hours after exercise and protein intake, before training intervention
Secondary Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA 30 min before exercise and protein intake, after 11-12 weeks of strength training
Secondary Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA 30 min after exercise and protein intake, after 11-12 weeks of strength training
Secondary Fasting cholesterol (only in elderly) Before training intervention
Secondary Fasting cholesterol (only in elderly) After 11-12 weeks of strength training
Secondary Fasting triglycerides (only in elderly) Before training intervention
Secondary Fasting triglycerides (only in elderly) After 11-12 weeks of strength training
Secondary Fasting LDL (only in elderly) Before training intervention
Secondary Fasting LDL (only in elderly) After 11-12 weeks of strength training
Secondary Fasting HDL (only in elderly) Before training intervention
Secondary Fasting HDL (only in elderly) After 11-12 weeks of strength training
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1